L3VLUP
ProSign in

MSA · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MSALLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MSA
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterMSALLY
Q3 20204 holders, $493m33 holders, $14.1bn
Q4 20203 holders, $481m29 holders, $17.3bn
Q1 20213 holders, $246m24 holders, $23.0bn
Q2 20213 holders, $265m24 holders, $27.8bn
Q3 20213 holders, $229m31 holders, $29.9bn
Q4 20211 holders, $228m31 holders, $34.7bn
Q1 20221 holders, $197m24 holders, $35.3bn
Q2 20221 holders, $2.8m33 holders, $42.7bn
Q3 20221 holders, $1.3m31 holders, $43.4bn
Q4 20222 holders, $16m31 holders, $46.6bn
Q1 20232 holders, $30m33 holders, $44.3bn
Q2 20232 holders, $46m37 holders, $59.6bn
Q3 20231 holders, $35m44 holders, $67.6bn
Q4 20234 holders, $49m45 holders, $73.6bn
Q1 20247 holders, $294m41 holders, $95.3bn
Q2 20244 holders, $274m43 holders, $110bn
Q3 20244 holders, $248m45 holders, $107bn
Q4 20245 holders, $277m46 holders, $93.9bn
Q1 20256 holders, $247m42 holders, $98.4bn
Q2 20256 holders, $444m43 holders, $93.2bn
Q3 20255 holders, $385m39 holders, $86.7bn
Q4 20256 holders, $324m41 holders, $123bn
Q1 20267 holders, $354m39 holders, $106bn
Q2 20264 holders, $367m44 holders, $132bn
MSA

Msa Safety Inc

Holders
4
Reported value
$367m
Buyers
20
Sellers
16

Breadth +4 among 91 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
44
Reported value
$132bn
Buyers
24
Sellers
24

Breadth 0 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2026

Among the 45 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MSA (1)

Ruane Cunniff & Goldfarb LP

Only LLY (41)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Discovery Capital Management LLC, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Harris Associates LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, and 16 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →